Table 1.
Variables with significant correlation with ACB, ARS, and ADS risk scores
| LEDD | AP tablet | AP drug | Total drug | Disease duration | Hoehn-Yahr stage | |
|---|---|---|---|---|---|---|
| ACB | ||||||
| r | 0.411 | 0.421 | 0.402 | 0.525 | 0.371 | 0.323 |
| p value | 0.001 | 0.001 | 0.002 | <0.001 | 0.004 | 0.013 |
| ARS | ||||||
| r | 0.499 | 0.567 | 0.600 | 0.353 | 0.398 | 0.165 |
| p value | <0.001 | <0.001 | <0.001 | 0.006 | 0.002 | 0.215 |
| ADS | ||||||
| r | 0.187 | 0.260 | 0.275 | 0.504 | 0.228 | 0.161 |
| p value | 0.159 | 0.048 | 0.036 | <0.001 | 0.086 | 0.226 |
ACB, Anticholinergic Cognitive Burden scale; ADS, Anticholinergic Drug Scale; ARS, Anticholinergic Risk Scale; LEDD, levodopa equivalent dose.